Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial
- Hyung Jin Choi, MD,
- Juyoun Yu, BS,
- Hosanna Choi, BS,
- Jee Hyun An, MD,
- Sang Wan Kim, MD, PHD,
- Kyong Soo Park, MD, PHD,
- Hak C. Jang, MD, PHD,
- Seong Yeon Kim, MD, PHD and
- Chan Soo Shin, MD, PHD
- From the Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- Corresponding author: Chan Soo Shin, csshin{at}snu.ac.kr.
Undercarboxylated osteocalcin (ucOC) is reported to function as an endocrine hormone, affecting glucose metabolism in mice (1,2). Vitamin K, which converts ucOC to carboxylated osteocalcin (cOC), has been suggested to regulate glucose metabolism by modulating osteocalcin and/or proinflammatory pathway (3–5).
We studied whether modulation of ucOC via vitamin K2 supplementation for 4 weeks affects β-cell function and/or insulin sensitivity in healthy young male subjects. Forty-two healthy young male volunteers received vitamin K2 (menatetrenone; 30 mg; Eisai Co., Japan) or placebo t.i.d. for 4 weeks. Frequently sampled intravenous glucose tolerance test was performed to determine insulin sensitivity index (Si), acute insulin response to glucose (AIRg), and disposition index (DI) before and after treatment. Adiponectin, interleukin (IL)-6, C-reactive protein (CRP), ucOC, and cOC …
In this Issue
